Series A startup

Who invested in DTRM Biopharma

One round we have observed, with the one investor named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Pharma

Funding summaryUpdated 26 Oct 2026

$60Mraised across 1 round since 2018, from 1 source

Latest round
Series A, $60MJan 2018
Investors
1
See who backed them

The rounds

  1. Jan 2018
    Series A$60M

    Source recorded

Everyone who backed them

Green Pine CapitalVC firm1round

Missing a round, or an investor who was in one? Tell us.

Quick answers about DTRM Biopharma

Who invested in DTRM Biopharma?

DTRM Biopharma's investors include Green Pine Capital.

How much has DTRM Biopharma raised?

DTRM Biopharma has raised $60M across 1 round since 2018.

When did DTRM Biopharma last raise?

DTRM Biopharma's most recent round was a Series A of $60M in Jan 2018.

What was DTRM Biopharma's biggest round?

Its most recent round, $60M in Jan 2018, is also its largest on record.

Who backed DTRM Biopharma first?

DTRM Biopharma's first round on record, in Jan 2018, was backed by Green Pine Capital.

What stage is DTRM Biopharma at?

DTRM Biopharma's latest named round is a Series A, in Jan 2018.

Companies like DTRM Biopharma

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.